Cryptococcus neoformans induces macrophage inflammatory protein 1α (MIP-1α) and MIP-1β in human microglia:: Role of specific antibody and soluble capsular polysaccharide

被引:32
作者
Goldman, D
Song, XY
Kitai, R
Casadevall, A
Zhao, ML
Lee, SC
机构
[1] Yeshiva Univ Albert Einstein Coll Med, Dept Pediat, Bronx, NY 10461 USA
[2] Yeshiva Univ Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10461 USA
[3] Yeshiva Univ Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA
[4] Yeshiva Univ Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA
关键词
D O I
10.1128/IAI.69.3.1808-1815.2001
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We characterized the expression of the beta -chemokines macrophage inflammatory protein 1 alpha (MIP-1 alpha), MIP-1 beta, and RANTES by primary human microglia after exposure to Cryptococcus neoformans. In the absence of specific antibody, C, neoformans failed to elicit a chemokine response, while in the presence of specific antibody, microglia produced MIP-1 alpha and MIP-1 beta in amounts comparable to those induced by lipopolysaccharide, RANTES was also induced but at much lower levels. In addition to MIP-1 alpha and MIP-1 beta mRNA, we observed a robust induction of monocyte chemoattractant protein 1 and interleukin-8 mRNA following incubation of microglia with opsonized C. neoformans, In contrast, cryptococcal polysaccharide did not induce a chemokine response even when specific antibody was present and inhibited the MIP-1 alpha induction associated with antibody-mediated phagocytosis of C, neoformans, The role of the Fc receptor in the observed chemokine induction was explored in several experiments. Treatment of microglia with cytochalasin D inhibited internalization of C, neoformans but did not affect MIP-1 alpha induction. In contrast, treatment with herbimycin A, a tyrosine kinase inhibitor, inhibited MIP-1 alpha induction. Microglia stimulated with immobilized murine immunoglobulin also produced MIP-1 alpha and RANTES (MIP-1 alpha > RANTES), Our results show that microglia produce several chemokines when stimulated by C. neoformans in the presence of specific antibody and that this process is likely to be mediated by Fc receptor activation. This response can be down-regulated by cryptococcal capsular polysaccharide. These findings suggest a mechanism by which C. neoformans infections fail to induce strong inflammatory responses in patients with cryptococcal meningoencephalitis and have important implications for antibody therapy.
引用
收藏
页码:1808 / 1815
页数:8
相关论文
共 48 条
  • [1] Microglia express CCR5, CXCR4, and CCR3, but of these, CCR5 is the principal coreceptor for human immunodeficiency virus type 1 dementia isolates
    Albright, AV
    Shieh, JTC
    Itoh, T
    Lee, B
    Pleasure, D
    O'Connor, MJ
    Doms, RW
    González-Scarano, F
    [J]. JOURNAL OF VIROLOGY, 1999, 73 (01) : 205 - 213
  • [2] ANDERS KH, 1986, AM J PATHOL, V124, P537
  • [3] Role of the capsule in microglial cell-Cryptococcus neoformans interaction: impairment of antifungal activity but not of secretory functions
    Barluzzi, R
    Brozzetti, A
    Delfino, D
    Bistoni, F
    Blasi, E
    [J]. MEDICAL MYCOLOGY, 1998, 36 (04) : 189 - 197
  • [4] ROLE OF NITRIC-OXIDE AND MELANOGENESIS IN THE ACCOMPLISHMENT OF ANTICRYPTOCOCCAL ACTIVITY BY THE BV-2 MICROGLIAL CELL-LINE
    BLASI, E
    BARLUZZI, R
    MAZZOLLA, R
    TANCINI, B
    SALEPPICO, S
    PULITI, M
    PITZURRA, L
    BISTONI, F
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 1995, 58 (01) : 111 - 116
  • [5] Characterization of a murine monoclonal antibody to Cryptococcus neoformans polysaccharide that is a candidate for human therapeutic studies
    Casadevall, A
    Cleare, W
    Feldmesser, M
    Glatman-Freedman, A
    Goldman, DL
    Kozel, TR
    Lendvai, N
    Mukherjee, J
    Pirofski, LA
    Rivera, J
    Rosas, AL
    Scharff, MD
    Valadon, P
    Westin, K
    Zhong, ZJ
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (06) : 1437 - 1446
  • [6] THE MOUSE ANTIBODY-RESPONSE TO INFECTION WITH CRYPTOCOCCUS-NEOFORMANS - VH AND VL USAGE IN POLYSACCHARIDE BINDING-ANTIBODIES
    CASADEVALL, A
    SCHARFF, MD
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 174 (01) : 151 - 160
  • [7] CASADEVALL A, NEW CONCEPTS IMMUNOP
  • [8] Casadevall A, 1998, CRYPTOCOCCUS NEOFORM, P407
  • [9] STRUCTURE AND ANTIGENIC ACTIVITY OF THE CAPSULAR POLYSACCHARIDE OF CRYPTOCOCCUS-NEOFORMANS SEROTYPE-A
    CHERNIAK, R
    REISS, E
    SLODKI, ME
    PLATTNER, RD
    BLUMER, SO
    [J]. MOLECULAR IMMUNOLOGY, 1980, 17 (08) : 1025 - 1032
  • [10] INFECTIONS WITH CRYPTOCOCCUS-NEOFORMANS IN THE ACQUIRED IMMUNODEFICIENCY SYNDROME
    CHUCK, SL
    SANDE, MA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (12) : 794 - 799